Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer’s disease
- 1 November 2017
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 25 (21) , 5917-5928
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81573313)
This publication has 49 references indexed in Scilit:
- A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2017
- Multitarget drug design strategy against Alzheimer’s disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional propertiesBioorganic & Medicinal Chemistry, 2017
- Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget AgentsJournal of Medicinal Chemistry, 2016
- Influence of a curcumin derivative on hIAPP aggregation in the absence and presence of lipid membranesChemical Communications, 2015
- Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase InhibitorJournal of Medicinal Chemistry, 2014
- Multifunctional tacrine–flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's diseaseEuropean Journal of Medicinal Chemistry, 2013
- Oxidative stress in Alzheimer disease: A possibility for preventionNeuropharmacology, 2010
- Alzheimer's DiseaseNew England Journal of Medicine, 2010
- Forecasting the global burden of Alzheimer's diseaseAlzheimer's & Dementia, 2007
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002